You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Funded Evidence-Informed Regimens

Drug and regimen monographs and information sheets for patients provide information on dosing and administering cancer treatment protocols. They are for general reference and are not meant to replace prescribing information or physician recommendations.

If you have questions about ST-QBP funding on our website, please visit our Frequently Asked Questions page.

Find enhanced Regimen Patient Information Sheets, created in collaboration with patient and family advisors.

Regimens

37 Items
Cancer Type: Hematologic, Lymphoma - Non-Hodgkin's Intermediate Grade     
Intent: Curative
Funding:
New Drug Funding Program
    Rituximab - As Part of the MATRix Regimen in Newly Diagnosed, Previously Untreated PCNSL
May 2019
Cancer Type: Gynecologic, Endometrial     
Intent: Palliative
Funding:
ODB - General Benefit
  • medroxyprogesterone
Apr 2016
Cancer Type: Gynecologic, Endometrial     
Intent: Adjuvant, Curative
Funding:
ODB - General Benefit
  • medroxyprogesterone
Oct 2017
Cancer Type: Breast     
Intent: Palliative
Funding:
ODB - General Benefit
    medroxyprogesterone
May 2019
Cancer Type: Breast     
Intent: Palliative
Funding:
ODB - General Benefit
  • megestrol - oral tablets
May 2016
Cancer Type: Gynecologic, Endometrial     
Intent: Palliative
Funding:
ODB - General Benefit
  • megestrol - oral tablets
Oct 2017
Cancer Type: Gynecologic, Endometrial     
Intent: Adjuvant, Curative
Funding:
ODB - General Benefit
    megestrol - oral tablets
May 2019
Cancer Type: Gynecologic, Endometrial     
Intent: Palliative
Funding:
ODB - General Benefit
    megestrol - oral tablets
ODB - General Benefit
    tamoxifen
May 2019
Cancer Type: Hematologic, Multiple Myeloma     
Intent: Palliative
Funding:
ODB - General Benefit
    melphalan - oral tablets
ODB - General Benefit
    dexamethasone
Updated
Sep 2019
Cancer Type: Hematologic, Multiple Myeloma     
Intent: Palliative
Funding:
ODB - General Benefit
    melphalan - oral tablets
ODB - General Benefit
    prednisone
Jun 2019
Cancer Type: Hematologic, Rare Diseases     
Intent: Curative
Funding:
ODB - General Benefit
    mercaptopurine
ODB - General Benefit
    prednisone
May 2019
Cancer Type: Gastrointestinal, Pancreas     
Intent: Adjuvant
May 2019